PTCT vs MIRM
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
PTCT · PTC Therapeutics$65.44 ▼ 0.35%
MIRM · Mirum Pharmaceuticals$93.72 ▲ 0.19%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- PTCT -9.7%
- MIRM +34.4%
Head to head
| Metric | PTCT | MIRM |
|---|---|---|
| Price | $65.44 | $93.72 |
| Change today | ▼ 0.35% | ▲ 0.19% |
| Market cap | $5.47B | $6.12B |
| Return, 3 months | -12.3% | -5.0% |
| Return, year to date | -13.8% | +18.6% |
| Return, 1 year | -8.8% | +37.6% |
| P/E (TTM) | -49.2 | -6.5 |
| P/B | -28.6 | -112.9 |
| P/E percentile vs own 5y | 5th | 87th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +69.6% | +37.9% |
| Net profit growth (YoY) | -425.2% | -1,047.0% |
| Gross margin | 93.2% | 81.7% |
| Operating margin | 12.0% | -15.6% |
| Net margin | -9.2% | -139.2% |
| Return on equity | – | -703.0% |
| Analyst target vs. price | +52.6% | +64.8% |
| Analyst buy share | 82% | 100% |
| RSI (14) | 53 | 61 |
| 30-day volatility | 54.4% | 53.2% |
| Max drawdown, 1 year | -33.8% | -38.4% |
| Trend read | Leaning bullish | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- MIRM is the largest of the group by market value.
- MIRM has returned the most over the past year.
- PTCT carries the lowest trailing P/E.
- PTCT is growing revenue fastest.
- PTCT keeps the most profit per dollar of sales.
- MIRM has been the calmest stock over the last 30 days.